Inflammasome inhibitors: promising therapeutic approaches against cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammasome inhibitors: promising therapeutic approaches against cancer
Authors
Keywords
Inflammasome inhibitors, Therapeutics, Cancer
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-26
DOI
10.1186/s13045-019-0755-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AIM2 promotes non‐small‐cell lung cancer cell growth through inflammasome‐dependent pathway
- (2019) Minda Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
- (2018) Jonathon P. Audia et al. BASIC RESEARCH IN CARDIOLOGY
- DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
- (2018) Darren C. Johnson et al. NATURE MEDICINE
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma
- (2018) Dafei Chai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inhibition of ER stress-related IRE1α/CREB/NLRP1 pathway promotes the apoptosis of human chronic myelogenous leukemia cell
- (2018) Zheng Xu et al. MOLECULAR IMMUNOLOGY
- Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
- (2018) Joseph Flores et al. Nature Communications
- High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer
- (2017) Fei Qian et al. HUMAN PATHOLOGY
- The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor
- (2017) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
- (2017) Donnele Daley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1β secretion in human trophoblasts
- (2017) Kazuhiro Tamura et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway
- (2017) Rui Zhang et al. Oncology Letters
- Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway
- (2017) Meng Su et al. Drug Design Development and Therapy
- P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer
- (2017) Ju Young Bae et al. Oncotarget
- Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
- (2017) Joyce K. Thompson et al. Oncotarget
- A resurging boom in new drugs for epilepsy and brain disorders
- (2017) Iyan Younus et al. Expert Review of Clinical Pharmacology
- Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
- (2017) Melvin Kantono et al. Frontiers in Immunology
- Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
- (2016) Andrea Giannuzzo et al. INTERNATIONAL JOURNAL OF CANCER
- NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
- (2016) Ann M. Janowski et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon Regulatory Factor-1 Mediates Alveolar Macrophage Pyroptosis During LPS-Induced Acute Lung Injury in Mice
- (2016) Dongdong Wu et al. SHOCK
- Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
- (2016) Ryan Kolb et al. Nature Communications
- IL-1 drives breast cancer growth and bone metastasis in vivo
- (2016) Ingunn Holen et al. Oncotarget
- Functional and Evolutionary Analyses Identify Proteolysis as a General Mechanism for NLRP1 Inflammasome Activation
- (2016) Joseph Chavarría-Smith et al. PLoS Pathogens
- Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy
- (2016) Fang Yuan et al. PLoS One
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model
- (2015) Guang-Sen Zhang et al. CHINESE MEDICAL JOURNAL
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis
- (2015) Tere M. Williams et al. JOURNAL OF IMMUNOLOGY
- P2X7 receptors: role in bone cell formation and function
- (2015) A. Agrawal et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells
- (2015) Andrea Giannuzzo et al. Molecular Cancer
- Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway
- (2015) HUI GAO et al. Molecular Medicine Reports
- Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
- (2015) O J Harrison et al. Mucosal Immunology
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway
- (2015) Kun Liao et al. Theranostics
- Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2
- (2014) Linghui Nie et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
- (2014) Wenjie Guo et al. Autophagy
- Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
- (2014) Zanjing Zhai et al. BREAST CANCER RESEARCH AND TREATMENT
- Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
- (2014) Qian-Qian Zhang et al. International Journal of Biological Sciences
- Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression
- (2014) ZANJING ZHAI et al. Molecular Medicine Reports
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells
- (2014) Ying Qiu et al. PLoS One
- Inflammasomes in cancer: a double-edged sword
- (2014) Ryan Kolb et al. Protein & Cell
- The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation
- (2013) Naeha Subramanian et al. CELL
- Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly
- (2013) Tengchuan Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
- (2013) T. Fernandes-Alnemri et al. JOURNAL OF IMMUNOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection
- (2013) T. Ichinohe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NLRP3 Suppresses NK Cell-Mediated Responses to Carcinogen-Induced Tumors and Metastases
- (2012) M. T. Chow et al. CANCER RESEARCH
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis
- (2012) SE-LIM KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
- (2012) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma
- (2012) Weimin Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
- (2012) Bénédicte F. Py et al. MOLECULAR CELL
- Regulation of inflammasome signaling
- (2012) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome
- (2012) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis
- (2012) S. K. Drexler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- The inflammasome: in memory of Dr. Jurg Tschopp
- (2011) M Dagenais et al. CELL DEATH AND DIFFERENTIATION
- The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
- (2011) P. Menu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
- (2011) Gavin C. K. W. Koh et al. CLINICAL INFECTIOUS DISEASES
- P2X7 receptor antagonism in the treatment of cancers
- (2011) Sébastien Roger et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice
- (2011) Mattia Maroso et al. Neurotherapeutics
- The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
- (2011) Rebecca C. Coll et al. PLoS One
- P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells
- (2010) Andrew W. Farrell et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Differential Requirement for Caspase-1 Autoproteolysis in Pathogen-Induced Cell Death and Cytokine Processing
- (2010) Petr Broz et al. Cell Host & Microbe
- Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
- (2010) Elena Adinolfi et al. FASEB JOURNAL
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
- (2010) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
- (2010) Jun-Wei Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes
- (2010) L. M. Hill et al. JOURNAL OF IMMUNOLOGY
- P2X7 Receptor-Mediated Release of Cathepsins from Macrophages Is a Cytokine-Independent Mechanism Potentially Involved in Joint Diseases
- (2010) G. Lopez-Castejon et al. JOURNAL OF IMMUNOLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
- (2010) B. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-κB Pathway
- (2009) Zhang Bao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma
- (2009) Patrick A. Ott et al. CHEMOTHERAPY
- Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer
- (2009) Siow Ming Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
- (2009) Y.N. V. Gopal et al. MOLECULAR CANCER THERAPEUTICS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Inflammatory Activity of Parthenolide-Depleted Feverfew (Tanacetum parthenium)
- (2009) R. Sur et al. INFLAMMOPHARMACOLOGY
- Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide
- (2008) Ming-Der Shi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity
- (2008) Iris Breitkreutz et al. Expert Opinion on Drug Metabolism & Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation